Praxis Precision Medicines, Inc. (PRAX) › Operating Cash FlowPraxis Precision Medicines, Inc. (PRAX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$33.42M2020: -$52.62M2021: -$124.55M2022: -$185.04M2023: -$111.14M2024: -$131.76M2025: -$249.07M-$249.07M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$249.07M-89.0%2024-$131.76M-18.6%2023-$111.14M+39.9%2022-$185.04M-48.6%2021-$124.55M-136.7%2020-$52.62M-57.5%2019-$33.42M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share